Turnstone Biologics Corp.
Stock Forecast, Prediction & Price Target
Turnstone Biologics Corp. (TSBX) stock Price Target by analysts
$0.5
Potential upside: 40.84%
Turnstone Biologics Corp. price prediction
What is Turnstone Biologics Corp. stock analysts` prediction?
Turnstone Biologics Corp. stock forecast: Based on 1 Wall Street analysts` predicted price targets for Turnstone Biologics Corp. in the last 3 months, the avarage price target is $0.5, with a high forecast of $NaN. The average price target represents a 40.84% change from the last price of $0.36.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Turnstone Biologics Corp. stock Price Target by analysts
Full breakdown of analysts given Turnstone Biologics Corp. price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Charlie Yang Bank of America Securities | 0% 0/1 | 11 months ago | $0.5 40.84% upside | $0.46 | StreetInsider | Previous targets (0) |
Turnstone Biologics Corp. Financial Estimates
Turnstone Biologics Corp. Revenue Estimates
Turnstone Biologics Corp. EBITDA Estimates
Turnstone Biologics Corp. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $101.29M N/A | $73.3M -27.63% | $19.30M -73.66% | Avg: $4.70M Low: $4.70M High: $4.70M avg. -75.64% | Avg: $2.32M Low: $2.32M High: $2.32M avg. -50.64% | ||
Net Income
% change YoY
| $33.26M N/A | $-30.83M -192.68% | $-55.2M -79.02% | Avg: $-99.33M Low: $-45.32M High: $-27.40M avg. -79.96% | Avg: $-112.55M Low: $-34.80M High: $-34.57M avg. -13.29% | ||
EBITDA
% change YoY
| $34.38M N/A | $-27.72M -180.63% | $-56.23M -102.82% | Avg: $-1.62M Low: $-1.62M High: $-1.62M avg. 97.10% | Avg: $-803.52K Low: $-803.52K High: $-803.52K avg. 50.64% | ||
EPS
% change YoY
| $1.5 N/A | -$1.39 -192.66% | -$4.77 -243.16% | Avg: -$3.01 Low: -$3.92 High: -$2.37 avg. 36.89% | Avg: -$3 Low: -$3.01 High: -$2.99 avg. 0.33% | ||
Operating Expenses
% change YoY
| $68.3M N/A | $104.92M 53.62% | $78.33M -25.33% | Avg: $2.04M Low: $2.04M High: $2.04M avg. -97.38% | Avg: $1.01M Low: $1.01M High: $1.01M avg. -50.64% | ||
FAQ
What is Turnstone Biologics Corp. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -46.63% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -45.32M, average is -99.33M and high is -27.40M.
What is Turnstone Biologics Corp. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -63.14% in 2025-2026.
We have gathered data from 2 analysts. Their low revenue estimate is $4.70M, average is $4.70M and high is $4.70M.
What is Turnstone Biologics Corp. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 18.61% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$3.92, average is -$3.01 and high is $-2.37.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Turnstone Biologics Corp. stock. The most successful analyst is Charlie Yang.